Crescent Capital BDC (CCAP) EBITDA (2021 - 2026)

Crescent Capital BDC's EBITDA history runs 6 years deep, the most recent figure standing at -$21.9 million for Q1 2026.

• Quarterly EBITDA fell 231.57% year-over-year to -$21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$179.8 million (down 673.24% YoY) and the FY2025 annual result came in at -$98.7 million, down 210.84% from the prior year.
• EBITDA was -$21.9 million for Q1 2026 at Crescent Capital BDC, up from -$149.1 million in the prior quarter.
• Across five years, EBITDA topped out at $156.0 million in Q4 2023 and bottomed at -$149.1 million in Q4 2025.
• A 5-year average of $1.4 million and a median of -$14.1 million in 2022 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA surged 223.89% — and 2025, when it plunged 828.39%.
• Crescent Capital BDC's EBITDA stood at $98.2 million in 2022, then surged by 58.93% to $156.0 million in 2023, then plunged by 86.88% to $20.5 million in 2024, then plunged by 828.39% to -$149.1 million in 2025, then jumped by 85.34% to -$21.9 million in 2026.
• Business Quant data shows CCAP's EBITDA at -$21.9 million in Q1 2026, -$149.1 million in Q4 2025, and $16.9 million in Q3 2025.